WHO ICTRP trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in…
CTIS2023-503697-21-01 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2023-503697-21-01 |
|---|---|
| Public title | A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis |
| Scientific title | A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis - IM027068 |
| Primary sponsor | Bristol-Myers Squibb Services Unlimited Company |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): Yes Therapeutic use - (Phase IV): No |
| Countries | Taiwan;Switzerland;Chile;India;China;Puerto Rico;Mexico;Argentina;United States;Israel;Brazil;United Kingdom;Australia;Korea, Republic… |
| Conditions | Idiopathic pulmonary fibrosis MedDRA version: 21.1Level: PTClassification code: 10021240Term: Idiopathic pulmonary fibrosis Class: 100000004855;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] |
| Interventions | Product Name: LPA1 antagonist, Product Code:PRD10258573, Pharmaceutical Form: FILM-COATED TABLET, Other descriptive name: , Strength: , Product Name: Placebo for BMS-986278, Product Code:N/A, Pharmaceutical Form: N/A, Other descriptive… |
| Registration date | Jun 2, 2024 |
| Target size | 1201 |
| Secondary IDs | U1111-1287-7529 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: